FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

322312007: Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    3681546019 Acetaminophen 325 mg and propoxyphene 32.5 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    3681548018 Dextropropoxyphene 32.5 mg and paracetamol 325 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    3681549014 Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    56964901000001111 Co-proxamol 32.5mg/325mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing dextropropoxyphene and paracetamol false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Non-opioid analgesic false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier 1
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has basis of strength substance Dextropropoxyphene false Inferred relationship Existential restriction modifier 1
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator value 32.5 false Inferred relationship Existential restriction modifier 1
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier 2
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has basis of strength substance Paracetamol false Inferred relationship Existential restriction modifier 2
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator value 325 false Inferred relationship Existential restriction modifier 2
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 2
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has precise active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier 1
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has precise active ingredient Paracetamol false Inferred relationship Existential restriction modifier 2
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has specific active ingredient Paracetamol false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has specific active ingredient Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Co-proxamol false Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Paracetamol+dextropropoxyphene hydrochloride 325mg/32.5mg tablet Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (A A H Pharmaceuticals Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Approved Prescription Services) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (IVAX Pharmaceuticals UK Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Kent Pharma (UK) Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Sandoz Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Ranbaxy (UK) Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Zentiva Pharma UK Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Unichem Plc) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Almus Pharmaceutical Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets 100 tablet Is pack of False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets 30 tablet Is pack of False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Meda Pharmaceuticals Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets 100 tablet Has VMP False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets 30 tablet Has VMP False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Phoenix Healthcare Distribution Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Sigma Pharmaceuticals Plc) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (DE Pharmaceuticals) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets (Part VIIID Drug Tariff Special Order) Is a False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-proxamol 32.5mg/325mg tablets 1 tablet Has VMP False Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start